top of page

RetireSimplyRadio Group

Public·2 members

Pathophysiology and Clinical Management of Uterine Fibroids (Leiomyomas)

Uterine fibroids are non-cancerous growths of the uterus that frequently appear during childbearing years. Also called leiomyomas or myomas, these tumors develop from the smooth muscle tissue of the uterus (myometrium). A single cell divides repeatedly, eventually creating a firm, rubbery mass distinct from neighboring tissue.



Growth Patterns and Classification

Fibroids are categorized by their location:

  • Intramural: Grow within the muscular uterine wall.

  • Submucosal: Bulge into the uterine cavity; these are most associated with heavy menstrual bleeding.

  • Subserosal: Project to the outside of the uterus.

Hormonal Influence

Growth is heavily influenced by estrogen and progesterone. Fibroids contain more estrogen and progesterone receptors than normal uterine muscle cells do. They tend to swell during pregnancy when hormone levels are high and shrink after menopause when hormone levels decline. Treatment ranges from hormonal suppression to surgical interventions like myomectomy or uterine artery embolization.

2 Views

SUBSCRIBE TO OUR NEWSLETTER

Thanks for submitting!

© 2035 RETIRESIMPLY®

Investment advisory services offered through Foundations Investment Advisors, LLC (“Foundations”), an SEC registered investment adviser. Nothing on this website constitutes investment, legal or tax advice, nor that any performance data or any recommendation that any particular security, portfolio of securities, transaction, investment or planning strategy is suitable for any specific person. Personal investment advice can only be rendered after the engagement of Foundations, execution of required documentation, and receipt of required disclosures. Investments in securities involve the risk of loss. Any past performance is no guarantee of future results. Advisory services are only offered to clients or prospective clients where Foundations and its advisors are properly licensed or exempted. For more information, please go to https://adviserinfo.sec.gov and search by our firm name or by our CRD #175083.

bottom of page